Triple Negative Breast Cancer Clinical Trials

ReadTheTrial indexes 4 studies for Triple Negative Breast Cancer. The most common development stage is Phase 2 (3 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

4 clinical trials found for Triple Negative Breast Cancer.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 3
75%
Phase 1 1
25%

Trial Status Breakdown

Trials for Triple Negative Breast Cancer

Precision Platform Study of Refractory Triple-negative Breast Cancer Based on Molecular Subtyping（(A Phase II, Open-label, Single-center Platform Study）

NCT05749588 · RECRUITING · Phase 2

A Randomized Non-comparative Open-label Phase 1b/2 Study of Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced Triple Negative Breast Cancer. "TRIFOUR Study"

NCT05181462 · ACTIVE NOT RECRUITING · Phase 2

An Open-label Phase II Trial Evaluating the Efficacy and Safety of Sintilimab Plus Anlotinib Combined With Chemotherapy as Neoadjuvant Therapy in Early-stage Triple-negative Breast Cancer（NeoSACT）

NCT04877821 · COMPLETED · Phase 2

PAveMenT: Phase Ib Study of Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer

NCT04360941 · RECRUITING · Phase 1

Frequently Asked Questions

What clinical trials are available for Triple Negative Breast Cancer?

There are 4 clinical trials listed for Triple Negative Breast Cancer. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Triple Negative Breast Cancer trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Triple Negative Breast Cancer trials in?

Current Triple Negative Breast Cancer trials are distributed across: Phase 2 (3), Phase 1 (1).

Find More Trials